NCT05102084

Brief Summary

Aim: This study was conducted to determine the effect of listening to music during CPAP on the agitation levels of intensive care patients who underwent CPAP due to COVID-19 and their compliance with the treatment. Study Design: This study is a prospective, randomized, controlled clinical trial. Seventy-six intensive care patients with COVID-19 were included in this study and assigned to the music and control groups via the block randomization method. The study was completed with 70 patients. In this study, the patients and outcome assessors were not blinded. The Richmond Agitation and Sedation Scale (RASS) level, respiratory rate, oxygen saturation (SpO2), and mask air leakage amount were the result criteria. Results: The mean RASS score of the patients in the intervention group was 2.14±0.69 before CPAP, 1.63±064 at the 1st minute, 0.89±0.58 at the 15th minute, and 0.74±0.61 at the 30th minute. The mean RASS score of the patients in the control group was 2.06±0.53 before CPAP, 1.80±0.58 at the 1st minute, 1.43±0.60 at the 15th minute, and 1.46±0.61 at the 30th minute of CPAP. There was a statistically significant difference between the groups at the 15th and 30th minutes (t=-3.81, p \< .001; t=-4.89, p \< .001, respectively).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 1, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

May 26, 2023

Status Verified

May 1, 2023

Enrollment Period

3 months

First QC Date

October 20, 2021

Last Update Submit

May 25, 2023

Conditions

Keywords

Covid-19CpapAdaptlisten to music

Outcome Measures

Primary Outcomes (2)

  • Changes in agitation level

    The agitation levels of patients were monitored with the Richmond Agitation and Sedation Scale

    30 minutes

  • Compliance with CPAP

    Measure of respiratory rate, oxygen saturation,mask air leakage amount

    30 minutes

Secondary Outcomes (1)

  • Variation of agitation and CPAP compliance with time

    30 minutes

Study Arms (2)

Experimental group

EXPERIMENTAL

Patients listening to music during CPAP application

Device: Listening to music with a bluetooth headset to patients receiving CPAP support

Control group

NO INTERVENTION

Patients not listening to music during CPAP application

Interventions

Listening to music with a bluetooth headset during the CPAP application to the patients and checking the compatibility on the CPAP device.

Experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over 18 years old
  • Received CPAP treatment for 1 day in the intensive care unit,
  • Not hearing impaired,
  • No sedation treatment
  • Not diagnosed with a psychiatric illness,
  • Hemodynamically stable,
  • Not taking drugs (such as digoxin, adrenaline, dopamine) that affect blood pressure and pulse rate
  • Patients with a Glasgow Coma Scale score of 14 and above will be accepted.

You may not qualify if:

  • The patient's desire to leave the study
  • be under the age of 18
  • putting the patient on mechanical ventilation
  • have a hearing impairment
  • Receiving sedation therapy
  • diagnosed with psychiatric illness
  • Using drugs (such as digoxin, adrenaline, dopamine) that affect blood pressure and pulse rate
  • Patients with a Glasgow Coma Scale score below 14 will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University

Erzurum, 25240, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19Microcephaly, Primary Autosomal Recessive, 6

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Reva Balcı Akpınar, Prof. Dr

    https://avesis.atauni.edu.tr/reva

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Nursing Fundamentals Graduate Student

Study Record Dates

First Submitted

October 20, 2021

First Posted

November 1, 2021

Study Start

September 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

May 26, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations